title: Low dose of orally administered antigen down-regulates the T helper type 2-response in a murine model of dust mite hypersensitivity.
abstract: One of the main goals of immunotherapy of allergic diseases is the down-regulation of the type I hypersensitivity reaction. We investigated in this study the effect of oral administration of varying doses (0.25, 1.0, 4.0 and 10 mg) of dust mite extract (Dermatophagoides pteronyssinus, Dp) in sensitized A/Sn mice. A marked decrease of the allergen-specific immunoglobulin E (IgE) response was observed with all antigen doses. The mice orally tolerized with low Dp dose (0.25 mg) had a significant decrease in the total serum IgE and in the immunoglobulin G1 (IgG1), IgG2a and IgG2b antibody levels. The higher Dp dose (10.0 mg), however, enhanced the IgG1 antibody response, suggesting the stimulation of a pre-existing immune response of the sensitized animals. Animals fed with the low Dp dose had a significant decrease in the frequency of interleukin-4 (IL-4) secreting cells. These animals also showed a significant decrease in the frequency of Dp-specific IgE- and IgG1-positive plasma cells. Our data suggest that feeding dust mite extract to Dp-sensitized mice down-regulates the development of type I hypersensitivity, by inhibition of the T helper 2 response.
authors.affiliation: Laboratório de Alergia e Imunologia Clinica e Experimental-LIM 56, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
authors.forename: M N
authors.initials: MN
authors.lastname: Sato
authors.forename: A F
authors.initials: AF
authors.lastname: Carvalho
authors.forename: A O
authors.initials: AO
authors.lastname: Silva
authors.forename: M
authors.initials: M
authors.lastname: MacIel
authors.forename: A E
authors.initials: AE
authors.lastname: Fusaro
authors.forename: A J
authors.initials: AJ
authors.lastname: Duarte
mesh_terms: D000284:Administration, Oral; D000818:Animals; D000941:Antigens / Q000008:administration & dosage*; D039741:Antigens, Dermatophagoides; D003888:Desensitization, Immunologic; D004334:Drug Administration Schedule; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006023:Glycoproteins / Q000008:administration & dosage*; D006969:Hypersensitivity, Immediate / Q000276:immunology / Q000628:therapy*; D007073:Immunoglobulin E / Q000097:blood; D007074:Immunoglobulin G / Q000097:blood; D015847:Interleukin-4 / Q000097:blood; D051379:Mice; D008815:Mice, Inbred Strains; D010950:Plasma Cells / Q000276:immunology; D018418:Th2 Cells / Q000276:immunology*
chemical_list: D000941:Antigens; D039741:Antigens, Dermatophagoides; D006023:Glycoproteins; D007074:Immunoglobulin G; D015847:Interleukin-4; D007073:Immunoglobulin E